Global Heart-lung Machines Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Single Roller Pump and Double Roller Pump.By Application;
Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment, and Others.By End-User;
ASCs and Hospitals.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Heart-lung Machines Market (USD Million), 2021 - 2031
In the year 2024, the Global Heart-lung Machines Market was valued at USD 413.16 million. The size of this market is expected to increase to USD 629.49 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.2%.
The Global Heart-lung Machines Market is witnessing robust growth driven by a myriad of factors, including the increasing prevalence of cardiovascular diseases, advancements in surgical techniques, and expanding healthcare infrastructure worldwide. Heart-lung machines play a pivotal role in cardiac and pulmonary surgeries by temporarily assuming the functions of the heart and lungs, ensuring oxygenation and circulation during complex procedures. With the rising burden of heart-related ailments such as coronary artery disease, heart failure, and congenital heart defects, the demand for heart-lung machines is experiencing a steady uptrend, particularly in developed regions where access to advanced medical care is readily available.
Technological innovations and product advancements are reshaping the landscape of the heart-lung machines market, with manufacturers focusing on developing more efficient, user-friendly, and portable devices. Miniaturization of components, integration of advanced monitoring systems, and incorporation of artificial intelligence are some of the key trends driving market growth. Additionally, increasing investments in research and development aimed at enhancing the safety, efficacy, and performance of heart-lung machines are further propelling market expansion. As healthcare systems strive to improve patient outcomes and minimize procedural risks, the demand for innovative heart-lung machines equipped with cutting-edge features continues to surge.
The global heart-lung machines market is witnessing significant opportunities for growth in emerging economies, fueled by rising healthcare expenditure, growing awareness about advanced treatment options, and improving access to healthcare services. Government initiatives aimed at addressing the burden of cardiovascular diseases and enhancing healthcare infrastructure are creating a conducive environment for market growth in these regions. However, challenges such as high cost of equipment, stringent regulatory requirements, and shortage of skilled perfusionists remain key areas of concern. Despite these challenges, the global heart-lung machines market is poised for remarkable expansion in the coming years, driven by technological innovations, increasing demand for minimally invasive surgeries, and a growing emphasis on improving patient outcomes in cardiac and pulmonary care.
Global Heart-lung Machines Market Recent Developments
-
In September 2022, LivaNova received FDA 510(k) clearance for its Essenz heart-lung machine (HLM), allowing the company to launch it commercially in the U.S. Essenz HLM has also been approved by Health Canada and the Japanese PMDA. Earlier, LivaNova introduced Essenz in Europe through a limited commercial launch.
-
In March 2023, LivaNova announced that they had received the U.S. FDA 510(k) clearance for their Essenz heart-lung machine intended for cardiopulmonary bypass (CPB) procedures. This machine is incorporated with advanced cable management and components for smooth user interface and better clinical results. This regulatory approval helped the company to enhance their R&D capabilities and increase their business revenue.
Segment Analysis
This comprehensive report on the Global Heart-lung Machines Market offers a detailed analysis of various market segments, including segmentation by application, end-user, type, and geographical region. Each segment is meticulously examined to provide a thorough understanding of market dynamics, trends, and growth opportunities. The report incorporates revenue analysis for both historic and forecast periods, allowing stakeholders to assess past performance and anticipate future market trends. Moreover, the analysis for each market segment is supported by relevant data points, ensuring the credibility and reliability of insights presented.
Through the utilization of robust data analytics techniques, this report identifies and interprets key data trends and patterns within the heart-lung machines market. These insights are derived from comprehensive data sets encompassing factors such as market size, growth rates, competitive landscape, regulatory environment, and technological advancements. By delving into the intricacies of data trends and patterns, the report offers valuable insights into market dynamics, including drivers, restraints, challenges, and opportunities influencing each segment. This data-driven approach enables stakeholders to make informed decisions and formulate effective strategies for business growth and market expansion.
The report goes beyond surface-level analysis by providing in-depth insights into the underlying factors shaping the Global Heart-lung Machines Market. By examining data trends and patterns from multiple perspectives, including historical performance, current market conditions, and future projections, the report offers a holistic view of the market landscape. This holistic approach enables stakeholders to gain a deeper understanding of market dynamics and navigate complexities effectively. Overall, this report serves as a valuable resource for industry participants, investors, policymakers, and other stakeholders seeking actionable insights and strategic guidance in the dynamic and evolving Global Heart-lung Machines Market landscape.
Global Heart-lung Machines Segment Analysis
In this report, the Global Heart-lung Machines Market has been segmented by Type, Application, End-User and Geography.
Global Heart-lung Machines Market, Segmentation by Type
In this report, the Global Heart-lung Machines Market has been segmented by Type into Single Roller Pump and Double Roller Pump.
Segmentation of the global heart-lung machines market by type into single roller pump and double roller pump delineates the different mechanisms used in these critical medical devices. Single roller pump heart-lung machines feature a single roller mechanism for pumping blood through the extracorporeal circuit during cardiac or pulmonary procedures. These machines are known for their simplicity and reliability, offering a cost-effective solution for healthcare facilities requiring circulatory support during surgeries. Single roller pump systems are often preferred for their ease of operation and maintenance, making them suitable for a wide range of cardiovascular interventions.
In contrast, double roller pump heart-lung machines utilize two rollers to create pulsatile flow within the extracorporeal circuit, mimicking the natural cardiac cycle more closely. This type of heart-lung machine is designed to provide enhanced hemodynamic stability and oxygenation during complex cardiac surgeries, where precise control of blood flow dynamics is critical. Double roller pump systems offer greater versatility and customization options, allowing healthcare providers to tailor perfusion parameters according to the specific needs of each patient and procedure. While double roller pump machines may be more complex to operate and maintain compared to their single roller pump counterparts, they are valued for their advanced functionality and performance in demanding surgical environments.
The segmentation of the global heart-lung machines market by type into single roller pump and double roller pump reflects the diverse requirements and preferences of healthcare providers and cardiac surgeons worldwide. While single roller pump machines offer simplicity and cost-effectiveness, double roller pump systems provide advanced hemodynamic control and pulsatile flow characteristics desired for complex cardiac procedures. Manufacturers of heart-lung machines need to cater to both segments of the market by offering a range of products that meet varying clinical needs, ensuring accessibility and efficacy across different healthcare settings.
Global Heart-lung Machines Market, Segmentation by Application
In this report, the Global Heart-lung Machines Market has been segmented by Application into Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment, and Others.
The segmentation of the global heart-lung machines market by application into cardiac surgeries, lung surgeries, acute respiratory failure treatment, and others reflects the diverse spectrum of medical interventions where these devices play a critical role. Cardiac surgeries represent the largest segment of the market, encompassing procedures such as coronary artery bypass grafting (CABG), valve replacement, and heart transplantation. Heart-lung machines are essential during cardiac surgeries to temporarily replace the functions of the heart and lungs, allowing surgeons to perform intricate procedures while maintaining oxygenation and circulation.
Lung surgeries comprise another significant segment of the market, including procedures such as lung transplantation, lobectomy, and pneumonectomy. Heart-lung machines are utilized during lung surgeries to provide circulatory support and oxygenation, enabling surgeons to perform pulmonary interventions with precision and safety. As the prevalence of lung diseases and the demand for lung transplantation continue to rise globally, the market for heart-lung machines in lung surgeries is expected to witness steady growth, driven by advancements in surgical techniques and medical technology.
Heart-lung machines play a crucial role in the treatment of acute respiratory failure, including conditions such as acute respiratory distress syndrome (ARDS) and severe pneumonia. In cases where patients' lungs are unable to provide adequate oxygenation, extracorporeal membrane oxygenation (ECMO) using heart-lung machines offers a life-saving intervention by temporarily supporting respiratory function. This application represents a growing segment of the market, particularly as ECMO technology evolves and becomes more widely available in healthcare facilities worldwide. Furthermore, the "others" category encompasses a range of specialized applications where heart-lung machines may be utilized, such as pediatric cardiac surgeries, congenital heart defect repairs, and research purposes, highlighting the versatility and adaptability of these devices across various clinical settings.
Global Heart-lung Machines Market, Segmentation by End-User
In this report, the Global Heart-lung Machines Market has been segmented by End-User into ASCs and Hospitals.
The segmentation of the global heart-lung machines market by end-users into Ambulatory Surgical Centers (ASCs) and hospitals reflects the diverse settings where cardiovascular surgeries are performed and the varying requirements of healthcare facilities. Hospitals, including both large medical centers and smaller community hospitals, represent a significant portion of the market due to their role as primary centers for complex cardiac procedures. These institutions typically have dedicated cardiac surgery departments equipped with advanced infrastructure and a multidisciplinary team of healthcare professionals capable of performing a wide range of cardiovascular interventions, including procedures requiring heart-lung machine support.
Ambulatory Surgical Centers (ASCs) have emerged as important contributors to the heart-lung machines market, particularly for less complex cardiovascular procedures and outpatient surgeries. ASCs offer several advantages, including cost-effectiveness, shorter wait times, and reduced risk of hospital-acquired infections. As advancements in medical technology enable the development of more compact and portable heart-lung machines, ASCs are increasingly equipped to handle a broader range of cardiovascular surgeries previously reserved for traditional hospital settings. This trend is fueled by the growing preference for minimally invasive procedures and the shift towards outpatient care models, driving the demand for heart-lung machines in ASCs.
The segmentation of the heart-lung machines market by end-users into ASCs and hospitals underscores the importance of tailoring product offerings and service models to meet the specific needs and preferences of each setting. While hospitals may require larger, more sophisticated heart-lung machines capable of supporting complex cardiac surgeries, ASCs may prioritize compact, user-friendly devices that enable efficient workflow and rapid turnover of patients. Manufacturers and suppliers of heart-lung machines need to adapt their strategies and product portfolios accordingly, leveraging innovations in technology and addressing regulatory requirements to effectively serve both ASCs and hospital customers in the global market.
Global Heart-lung Machines Market, Segmentation by Geography
In this report, the Global Heart-lung Machines Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Heart-lung Machines Market Share (%), by Geographical Region, 2024
The global heart-lung machines market exhibits diverse geographical distribution in terms of market share, influenced by factors such as healthcare infrastructure, prevalence of cardiovascular diseases, technological advancements, and regulatory frameworks. North America traditionally holds a significant share due to well-established healthcare systems, high adoption rates of advanced medical technologies, and a large patient pool requiring cardiovascular interventions. The region benefits from robust research and development activities, leading to the introduction of innovative heart-lung machines. Moreover, strategic collaborations between industry players and research institutions further drive market growth in North America.
Europe also commands a considerable share in the global heart-lung machines market, owing to the presence of leading medical device manufacturers, strong emphasis on healthcare quality and patient safety, and favorable reimbursement policies. Countries like Germany, the UK, and France are at the forefront of cardiac care and witness substantial demand for heart-lung machines. Additionally, increasing healthcare expenditure, rising geriatric population, and growing awareness about advanced treatment options contribute to market expansion across the European region. However, stringent regulatory requirements and pricing pressures may pose challenges to market players operating in this region.
The Asia Pacific region is experiencing rapid growth in the heart-lung machines market, driven by expanding healthcare infrastructure, rising healthcare spending, and the increasing prevalence of cardiovascular diseases in countries such as China, India, and Japan. Technological advancements and the adoption of minimally invasive surgical procedures also propel market growth in this region. Moreover, government initiatives to improve access to healthcare services and investments in medical research and development contribute to the expansion of the heart-lung machines market in Asia Pacific. However, disparities in healthcare access and reimbursement policies across different countries may affect market penetration to some extent.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Heart-lung Machines Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Technological Advancements
- Increasing Cardiovascular Surgeries
- Rising Prevalence of Heart Diseases
- Growing Aging Population
-
Surge in Organ Transplants : The surge in organ transplants has become a significant driver in the global heart-lung machines market. As advancements in medical science continue to improve the success rates of organ transplantation, there's a growing demand for heart-lung machines that can support these intricate procedures. With more individuals requiring life-saving organ transplants due to various health conditions such as heart failure or lung diseases, the need for reliable heart-lung machines has intensified. This surge in organ transplantation has not only increased the volume of surgeries but has also expanded the market for heart-lung machine manufacturers and suppliers.
The increasing acceptance and success of heart-lung transplantation as a viable treatment option for end-stage cardiac and pulmonary diseases have fueled the demand for heart-lung machines worldwide. Patients suffering from conditions that were previously deemed untreatable now have hope through organ transplantation, driving both healthcare providers and medical device manufacturers to invest more in this field. Additionally, advancements in organ procurement techniques, preservation methods, and surgical procedures have contributed to the growing number of organ transplants, further boosting the requirement for efficient heart-lung machines during these procedures.
The global rise in awareness about organ donation and transplantation, coupled with government initiatives and healthcare campaigns, has led to a significant increase in organ procurement rates. As more individuals and families consent to organ donation, the pool of available organs for transplantation expands, consequently driving the demand for heart-lung machines to support these surgeries. This surge in organ transplants not only saves lives but also presents a lucrative opportunity for stakeholders in the heart-lung machines market to innovate and develop advanced technologies that can further enhance the success and efficiency of organ transplantation procedures.
Restraints
- High Cost of Equipment
- Stringent Regulatory Policies
- Limited Access in Remote Areas
- Risk of Infections
-
Lack of Skilled Professionals : The lack of skilled professionals presents a significant challenge in the global heart-lung machines market, hindering the efficient operation and utilization of these critical medical devices. Heart-lung machines require specialized knowledge and training to operate effectively during complex cardiovascular surgeries. However, there is a shortage of healthcare professionals with the necessary expertise in handling these machines, including perfusionists who manage the circulation of blood and oxygen during procedures. This shortage can lead to inefficiencies in operating theaters, delays in surgeries, and increased risks for patients undergoing cardiovascular procedures.
The complexity of heart-lung machines necessitates ongoing education and training for healthcare professionals to stay updated with the latest advancements and best practices in perfusion technology. However, limited access to specialized training programs and resources exacerbates the shortage of skilled professionals in this field. As a result, healthcare institutions may struggle to recruit and retain qualified perfusionists, further exacerbating the problem and impacting the quality of care provided to patients requiring heart-lung support during surgeries.
Addressing the lack of skilled professionals in the heart-lung machines market requires collaborative efforts from healthcare organizations, educational institutions, and industry stakeholders. Investing in comprehensive training programs, continuing education initiatives, and mentorship opportunities can help cultivate a skilled workforce capable of proficiently operating and maintaining heart-lung machines. Additionally, leveraging technology such as simulation training and virtual reality platforms can enhance the learning experience and bridge the gap between theory and practical application. By prioritizing education and professional development in perfusion technology, healthcare systems can mitigate the challenges posed by the lack of skilled professionals and ensure optimal outcomes for patients undergoing cardiovascular surgeries.
Opportunities
- Innovations in Product Design
- Collaborations with Research Institutions
- Market Expansion in Developing Regions
- Customization for Specific Patient Needs
-
Focus on Portable Solutions : The growing focus on portable solutions in the global heart-lung machines market reflects a shift towards enhancing accessibility and flexibility in critical care settings. Traditional heart-lung machines are often large, stationary units that require dedicated space within hospitals or surgical centers. However, the demand for portable solutions has emerged due to the need for more versatile and mobile devices that can be deployed in various healthcare environments, including operating rooms, emergency departments, and transport vehicles. Portable heart-lung machines offer healthcare providers the flexibility to perform complex cardiovascular procedures in diverse settings, enabling timely intervention and improved patient outcomes.
Advancements in miniaturization technology and engineering have paved the way for the development of compact and lightweight portable heart-lung machines that maintain the same level of performance and functionality as their larger counterparts. These portable solutions are designed to be easily transportable and deployable, allowing for rapid setup and operation during emergency situations or in resource-limited settings. Additionally, portable heart-lung machines offer greater maneuverability and versatility, enabling healthcare providers to deliver life-saving care to patients across various clinical scenarios, including intra-hospital transfers and remote medical missions.
The adoption of portable heart-lung machines is driven by the growing trend towards minimally invasive surgical techniques and ambulatory care models. As healthcare delivery continues to evolve towards patient-centered care and shorter hospital stays, portable heart-lung machines enable clinicians to perform complex cardiac procedures with greater efficiency and reduced invasiveness. By offering greater mobility and adaptability, portable solutions empower healthcare providers to deliver high-quality cardiovascular care while maximizing resource utilization and improving overall patient satisfaction. As such, the focus on portable solutions represents a significant advancement in the global heart-lung machines market, with potential implications for transforming the landscape of cardiac surgery and critical care delivery.
Competitive Landscape Analysis
Key players in Global Heart-lung Machines Market include:
- Medtronic plc
- LivaNova PLC
- Terumo Corporation
- Getinge AB
- Sorin Group (Now part of LivaNova PLC)
- MAQUET Holding B.V. & Co. KG (A subsidiary of Getinge AB)
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End-User
- Market Snapshot, By Region
- Global Heart-lung Machines Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological Advancements
- Increasing Cardiovascular Surgeries
- Rising Prevalence of Heart Diseases
- Growing Aging Population
- Surge in Organ Transplants
- Restraints
- High Cost of Equipment
- Stringent Regulatory Policies
- Limited Access in Remote Areas
- Risk of Infections
- Lack of Skilled Professionals
- Opportunities
- Innovations in Product Design
- Collaborations with Research Institutions
- Market Expansion in Developing Regions
- Customization for Specific Patient Needs
- Focus on Portable Solutions
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Heart-lung Machines Market, By Type, 2021 - 2031 (USD Million)
- Single Roller Pump
- Double Roller Pump
- Global Heart-lung Machines Market, By Application, 2021 - 2031 (USD Million)
- Cardiac Surgeries
- Lung Surgeries
- Acute Respiratory Failure Treatment
- Others
- Global Heart-lung Machines Market, By End-User, 2021 - 2031 (USD Million)
- ASCs
- Hospitals
- Global Heart-lung Machines Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Heart-lung Machines Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Medtronic plc
- LivaNova PLC
- Terumo Corporation
- Getinge AB
- Sorin Group (Now part of LivaNova PLC)
- MAQUET Holding B.V. & Co. KG (A subsidiary of Getinge AB)
- Company Profiles
- Analyst Views
- Future Outlook of the Market